Alnylam Pharmaceuticals Target of Unusually High Options Trading
Alnylam Pharmaceuticals, Inc. was the recipient of some unusual options trading activity on Wednesday. Stock traders bought 30,530 call options on the stock.
from Biotech News
Alnylam Pharmaceuticals, Inc. was the recipient of some unusual options trading activity on Wednesday. Stock traders bought 30,530 call options on the stock.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments